Journals in Pharmaceutical sciences
Journals in Pharmaceutical sciences
Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.
- ISSN: 0731-7085
Journal of Pharmaceutical and Biomedical Analysis
This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradant... dealing with the analytical aspects of traditional folk medicines are acceptable if the results are expected to attract the interest of readers also outside the area of origin, i.e. they have a focus on innovative analytical approaches. Regional differences in the phytochemical content of traditional folk medicine will not be considered. Manuscripts reporting on the analysis of novel phytochemicals will only be considered if their biological activity has been previously published in an international medium. Pharmacokinetic studies of traditional folk medicine will only be considered if only the identified components have been demonstrated to be solely responsible for the pharmacological activity.Bioanalytic... papers (pharmacokinetic, bioequivalence, protein and DNA binding studies) are accepted if the focus is on innovative analytical methodology. Manuscripts describing the pharmacokinetic profile of a single compound will not be considered for review. Pharmacokinetic studies will only be considered if they offer new profiles of a drug(s) and its metabolite(s) or new understandings of the mechanisms in drug disposition or response of existing drugs. Analytical studies on new investigational drugs that are currently in the preclinical phase are only acceptable if their pharmacological activity is well documented in an international medium.Human subjects research must provide ethical approval and should include the name of the approving committee and the name of the institution and reference number where approval was granted. Animal studies must be approved from their Institutions Animal Care and Use Committee or any equivalent ethics committee accompanied by the reference number. For blood sampling procedures in rodents, retro-orbital bleeding will only be considered if a minimum of 7 days is allowed between repeat sampling. Furthermore, in the evaluation of the manuscript the editors reserve the right to determine whether the animal experimental technique is appropriate.In determining the suitability of submitted articles for publication, particular scrutiny will be placed on the degree of novelty and significance of the research and the extent to which it adds to existing knowledge in pharmaceutical and biomedical analysis. In all submissions to the journal, authors must address the question of how their proposed methodology compares with previously reported methods. A substantial body of work cannot be fractionated into different shorter papers.- ISSN: 0367-326X
Fitoterapia
The Journal for the Study of Medicinal PlantsA Q1-ranked journal in the category of 'Agricultural and Biological Sciences' (Scopus).Fitoterapia is a Journal dedicated to medicinal plants and fungi and to the bioactive natural products produced by these organisms. It publishes original contributions in seven major areas:1. Chemical characterization of active ingredients of medicinal plants and fungi, including their endophytes 2. New analytical approaches for dereplication and standardization of biologically active extracts and metabolites from plant resources 3. Identification of bioactivity in plant and fungal extracts and in their constituents 4. Identification of biological targets and mechanism of activity of plant and fungal extracts 5. Production and genomic characterization of medicinal plants biomass 6. Biosynthesis of bioactive natural products of plant, fungi and endophytic origin 7. Critical reviews of the composition, history, clinical and legal status of medicinal plants, and accounts on topical issues.Contributions reporting the following are NOT normally considered for publication: 1. Activity data on crude extracts that have not been characterized by analysis of their major constituents (HPLC fingerprint, LC/MS or NMR). Data on the extract composition simply taken from the literature are not acceptable. Characterization of only a few constituents is generally considered too partial. 2. Studies on the bioactivity of pure compounds purchased or obtained by Authors without any study or relationship with the producing organism. 3. Unexceptional and predictable bioactivity (e.g. antioxidant properties of phenolics or antibacterial activity of essential oils). 4. Uncritical ethnopharmacological investigations, where a list of plants and their use are simply recorded. 5. Genomic, transcriptomic and pharmacological studies without convincing wet lab experiments, or with little correlation to bioactive natural compounds.In addition, the following immediate rejection criteria apply: RULE 1: The manuscript does not fall into any of the areas of interest of the Journal. RULE 2: The manuscript is too preliminary, reporting e.g. activity data without comparison to a reference, or without a positive control. RULE 3: The botanical source is not clearly identified, authenticated, and documented (voucher). RULE 4: Characterization of new compounds without spectral supporting material. RULE 5: Bioactivity is not relevant to in vivo situations. RULE 6: Reviews on topics already covered in the recent literature.- ISSN: 0378-5173
International Journal of Pharmaceutics
The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher.Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles.- ISSN: 1877-1297
Currents in Pharmacy Teaching and Learning
Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricu... outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/... within pharmacy education- ISSN: 0169-409X
Advanced Drug Delivery Reviews
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center- ISSN: 0172-2190
World Patent Information
The journal for intellectual property information and its retrieval, documentation, classification, search, analysis and IP managementWorld Patent Information aims to encompass the world of IP information; and focus the journal towards IPRs for industrially applicable innovations; and their management, analysis; big data analysis; policy; education. IPRs - patents, utility models; copyright, trademarks, registered design; design rights; trade secrets; database rights; traditional knowledge; indigenous knowledge; geographical indications may all be considered.World Patent Information publishes articles regarding best practice in legal and commercial patent search and analysis; articles which focus on particular types of search such as freedom to operate, FTO, clearance, state of the art, invalidity, validity, prior art, technical, landscaping, scouting, forecasting, patentability, decision searching, competitive intelligence using patent information. We are also interested in articles researching into meta data relating to IPRs such as legal status data for IPR; classifications and bibliographic data. We are interested in IP documentation, search, documentation, classification and IP information news from IP Offices.Always welcome are reviews of state of the art in a particular industry, reviews of patent, and other IP and scientific and technical databases, search and analysis for IP purposes.Research and review articles on information related to non- patent IPRs , trademarks, trade names, brands, designs, copyright, trade secrets, traditional knowledge, semiconductor rights, database rights, where these have impact for the technological innovation space. Best practice search and review articles, on sources of data. IP management information issues, inventions harvesting, IP services and intermediates and use of text mining and data mining for IP interests. Information retrieval (IR) relating to all aspects of IP published information not only text but also document specific, e.g. bibliographic, name, geographic; multi-lingual search, image search, tables, other non-text; text mining, Natural Language Processing (NLP); Information Extraction from patents e.g. – mathematical formulae, chemical, biological, plant, related data; Machine Translation, Machine learning, automated intelligence focused towards improving IP search and analysis; System Evaluation and Benchmarking, Data collections for IR experiments; Best practice for IP; IP management of Patents, Trademarks,. designs, know-how, copyright, trade secrets; organization of IP tasks in companies and research institutions; Innovation management -impact of patent and IP management; information management for IP best practice, TRIZ and its implementation for innovation processes; Technology management –characteristics and dynamics of technologies in IP perspective, IP portfolio benchmarking, valuation, geographic, expiries, technological, Advanced analysis –market, corporate, policy level, statistical analysis, Business methods patenting, Standards - standard essential patents – patent pools.- ISSN: 0895-4356
Journal of Clinical Epidemiology
Metascience and innovative methods to improve population healthThe Journal of Clinical Epidemiology (JCE) aims to advance science that can improve health care decision-making and contribute to the evolving discipline of clinical epidemiology. The JCE publishes methods-focused articles across the spectrum of the research ecosystem, including primary research (qualitative, quantitative, and mixed); evidence syntheses; guidelines; and implementation science. The journal welcomes registered reports, protocols, and simulation studies that advance the journal’s aims. The JCE is committed to promoting equity, diversity, and inclusion across all its content, contributors, editorial board, and leadership. Priority is given to contributions from early and mid-career researchers and low- and middle-income countries.The journal publishes topics including:Meta-scien... researchDevelopment, evaluation, and implementation of reporting guidelines Research integrity and cultureOpen scienceEmerging methodologies Developing and evaluating outcome measuresEducation and learning programs for clinical epidemiologistThe JCE does not accept the following submissions except in exceptional circumstances: Bibliometric studies and those on infodemiology, social media trends, and health informaticsPapers written primarily for a statistical audience Artificial intelligence and machine learning studies without critical evaluation of the method and transparent reportingMeta-resear... studies that demonstrate weaknesses or limitations in the evidence ecosystem but lack reflection on how these might be addressedEffectivene... studies, including Mendelian randomization studies and target trial emulations; systematic reviews; prevalence and incidence studies; prognostic or diagnostic research where the main focus is not on the methodsStudies limited to one country, jurisdiction, or clinical area with limited generalizability, such as: translating an outcome measure into a different language; a study focused on one clinical specialty; a Delphi/consensus-bas... study where all the authors are from one country; or a survey of participants from one setting or with a limited response rateStudies with a single author where it was more appropriate for a multi-disciplinary team to conduct the researchStudies that do not include patient partners as members of the research team in circumstances where that would be considered essentialAnimal studies Pharmacovigilance and pharmacoepidemiology studies- ISSN: 0939-6411
European Journal of Pharmaceutics and Biopharmaceutics
Official Journal of the International Association for Pharmaceutical TechnologyThe European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.Top... covered include for example:Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)Aspects of manufacturing process designBiomedical aspects of drug product designStrategies and formulations for controlled drug transport across biological barriersPhysicochemi... aspects of drug product developmentNovel excipients for drug product designDrug delivery and controlled release systems for systemic and local applicationsNanomate... for therapeutic and diagnostic purposesAdvanced therapy medicinal productsMedical devices supporting a distinct pharmacological effect"The Rules of 3"The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work: 1. The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance. 2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented. 3. The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.- ISSN: 1773-2247
Journal of Drug Delivery Science and Technology
The Journal of Drug Delivery Science and Technology is an international journal devoted to drug delivery and pharmaceutical technology. It is the Offical Journal of the Association de Pharmacie Galenique Industrielle (APGI), Associazione Docenti e Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche (ADRITELF), and Academy of Pharmaceutical Science and Technology, Japan (APSTJ).The journal covers all innovative aspects of all pharmaceutical dosage forms and the most advanced research on: • Controlled release • Bioavailability and drug absorption • Nanomedicines • Gene delivery • Tissue engineering, etc.Hot topics, related to manufacturing processes and quality control, are also welcomed.- ISSN: 0168-3659
Journal of Controlled Release
The Journal of Controlled Release (JCR) is the Official Journal of the Controlled Release Society, and of the Japan Society of Drug Delivery System.It publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.Manuscrip... that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.